Clinical Trial Update: Sub-Cutaneous Insulin in Hyperglycaemic Emergencies [NA]

View source ↗

Summary

A clinical trial evaluating subcutaneous insulin for hyperglycemic emergencies has been withdrawn. The study was sponsored by The Royal Bournemouth Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)

Snippet

Sponsor: The Royal Bournemouth Hospital | Conditions: Diabetes Mellitus | NA | Status: WITHDRAWN